A Study Evaluating the Effects of the Body on and the Safety and Effectiveness of Mosunetuzumab in Patients with Relapsed or Refractory Follicular Lymphoma.

An Open-label, Multicenter, Phase I Trial Evaluating the Pharmacokinetics, Safety and Efficacy of Mosunetuzumab as a Single-agent in Patients with Relapsed or Refractory Follicular Lymphoma

Cancer
Non Hodgkin Lymphoma (NHL)
Follicular Lymphoma

Results
Download

Study results

LPS YO43555 Final Results November 2025 English (PDF, 0.7 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

A Study Evaluating the Effects of the Body on and the Safety and Effectiveness of Mosunetuzumab in Patients with Relapsed or Refractory Follicular Lymphoma.

Study results

LPS YO43555 Final Results November 2025 English (PDF, 0.7 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

External Site

Directly contact Roche for questions

Contact the hospital directly

You are about to leave ForPatients

Thank you

Request a call back

Find participating medical centers and current study status in each of them

A Study Evaluating the Effects of the Body on and the Safety and Effectiveness of Mosunetuzumab in Patients with Relapsed or Refractory Follicular Lymphoma.

For the latest version of this information please go to www.forpatients.roche.com